معرفی
Toral Surti is an Associate Professor of Psychiatry at Yale University School of Medicine, specializing in cognitive aspects of schizophrenia and related psychotic disorders. Her research focuses on understanding cognitive impairments in schizophrenia, sleep disorders in psychotic conditions, and the effects of cannabis on mental health and sleep patterns.
Dr. Surti's educational background includes a BS in Molecular Biophysics and Biochemistry from Yale College (1998), followed by an MD and PhD from the University of California at San Francisco (2007). She completed her residency at Yale University School of Medicine (2012) and a research fellowship at Yale University School of Medicine and VA Connecticut Healthcare System (2014).
Her primary research interests include cognition in schizophrenia, sleep disorders among individuals with psychotic disorders, and the intersection of cannabis use and mental health. Dr. Surti employs both clinical and neurobiological approaches to investigate cognitive training interventions, neuroplasticity, and novel pharmacological targets for cognitive enhancement in schizophrenia. Her work often examines how sleep disturbances impact cognitive function in psychotic disorders, and she has conducted significant research on cannabis effects on sleep architecture and cannabinoid receptor availability.
Dr. Surti's recent publications demonstrate a strong focus on translational research bridging basic neuroscience with clinical applications. Her work spans from molecular studies of receptor availability to clinical trials testing cognitive interventions. Several publications examine the relationship between cannabis use and mental health outcomes, while others focus on sleep disorders in schizophrenia. Her research often involves interdisciplinary collaboration across psychiatry, neuroscience, and biomedical engineering, as evidenced by her work on radar-based vital sign monitoring in clinical settings.
- Sleep apnea research showing the impact of respiratory disorders on cognition in schizophrenia
- Clinical trials of glycine transporter inhibitors for cognitive enhancement
- Studies on dopamine receptor stimulation as a pro-cognitive target
- Investigations of cannabis effects on sleep architecture
- Research on illness phase as a critical window for psychosis intervention
Dr. Surti serves as Principal Investigator for the 'Sleep Dependent Learning in Schizophrenia and Psychosis Risk Syndrome' study and is a Sub Investigator for multiple clinical trials investigating schizophrenia spectrum disorders, cannabis effects, and adolescent brain development. Her research program demonstrates a commitment to understanding the biological mechanisms underlying cognitive deficits in psychosis and developing targeted interventions.